rs8192613

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004588.5(SCN2B):​c.449-12C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.483 in 1,607,468 control chromosomes in the GnomAD database, including 191,531 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 16819 hom., cov: 32)
Exomes 𝑓: 0.49 ( 174712 hom. )

Consequence

SCN2B
NM_004588.5 intron

Scores

2
Splicing: ADA: 0.0002714
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.332

Publications

11 publications found
Variant links:
Genes affected
SCN2B (HGNC:10589): (sodium voltage-gated channel beta subunit 2) The protein encoded by this gene is the beta 2 subunit of the type II voltage-gated sodium channel. The encoded protein is involved in cell-cell adhesion and cell migration. Defects in this gene can be a cause of Brugada Syndrome, atrial fibrillation, or sudden infant death syndrome. [provided by RefSeq, Jul 2015]
SCN2B Gene-Disease associations (from GenCC):
  • atrial fibrillation, familial, 14
    Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Genomics England PanelApp
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-118167098-G-T is Benign according to our data. Variant chr11-118167098-G-T is described in ClinVar as Benign. ClinVar VariationId is 259446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.745 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN2BNM_004588.5 linkc.449-12C>A intron_variant Intron 3 of 3 ENST00000278947.6 NP_004579.1 O60939Q5U0K8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN2BENST00000278947.6 linkc.449-12C>A intron_variant Intron 3 of 3 1 NM_004588.5 ENSP00000278947.5 O60939

Frequencies

GnomAD3 genomes
AF:
0.462
AC:
70140
AN:
151890
Hom.:
16804
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.361
Gnomad AMI
AF:
0.447
Gnomad AMR
AF:
0.497
Gnomad ASJ
AF:
0.552
Gnomad EAS
AF:
0.766
Gnomad SAS
AF:
0.547
Gnomad FIN
AF:
0.567
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.467
GnomAD2 exomes
AF:
0.505
AC:
123691
AN:
244966
AF XY:
0.509
show subpopulations
Gnomad AFR exome
AF:
0.359
Gnomad AMR exome
AF:
0.484
Gnomad ASJ exome
AF:
0.543
Gnomad EAS exome
AF:
0.776
Gnomad FIN exome
AF:
0.544
Gnomad NFE exome
AF:
0.467
Gnomad OTH exome
AF:
0.498
GnomAD4 exome
AF:
0.486
AC:
706813
AN:
1455462
Hom.:
174712
Cov.:
40
AF XY:
0.488
AC XY:
353632
AN XY:
724196
show subpopulations
African (AFR)
AF:
0.349
AC:
11667
AN:
33432
American (AMR)
AF:
0.485
AC:
21632
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.547
AC:
14284
AN:
26124
East Asian (EAS)
AF:
0.770
AC:
30553
AN:
39678
South Asian (SAS)
AF:
0.554
AC:
47771
AN:
86222
European-Finnish (FIN)
AF:
0.541
AC:
26164
AN:
48354
Middle Eastern (MID)
AF:
0.462
AC:
2663
AN:
5766
European-Non Finnish (NFE)
AF:
0.470
AC:
521696
AN:
1110954
Other (OTH)
AF:
0.504
AC:
30383
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
17726
35453
53179
70906
88632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15766
31532
47298
63064
78830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.462
AC:
70195
AN:
152006
Hom.:
16819
Cov.:
32
AF XY:
0.470
AC XY:
34897
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.361
AC:
14971
AN:
41460
American (AMR)
AF:
0.498
AC:
7605
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.552
AC:
1911
AN:
3464
East Asian (EAS)
AF:
0.765
AC:
3942
AN:
5150
South Asian (SAS)
AF:
0.546
AC:
2629
AN:
4816
European-Finnish (FIN)
AF:
0.567
AC:
6003
AN:
10578
Middle Eastern (MID)
AF:
0.446
AC:
131
AN:
294
European-Non Finnish (NFE)
AF:
0.465
AC:
31601
AN:
67948
Other (OTH)
AF:
0.473
AC:
995
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1855
3710
5566
7421
9276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
5016
Bravo
AF:
0.456
Asia WGS
AF:
0.636
AC:
2207
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Atrial fibrillation, familial, 14 Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
11
DANN
Benign
0.59
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00027
dbscSNV1_RF
Benign
0.034
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8192613; hg19: chr11-118037813; API